 |
PDBsum entry 1xpr
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transcription/RNA
|
PDB id
|
|
|
|
1xpr
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Structural mechanism of inhibition of the rho transcription termination factor by the antibiotic bicyclomycin.
|
 |
|
Authors
|
 |
E.Skordalakes,
A.P.Brogan,
B.S.Park,
H.Kohn,
J.M.Berger.
|
 |
|
Ref.
|
 |
Structure, 2005,
13,
99.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Rho is a hexameric RNA/DNA helicase/translocase that terminates transcription of
select genes in bacteria. The naturally occurring antibiotic, bicyclomycin
(BCM), acts as a noncompetitive inhibitor of ATP turnover to disrupt this
process. We have determined three independent X-ray crystal structures of Rho
complexed with BCM and two semisynthetic derivatives,
5a-(3-formylphenylsulfanyl)-dihydrobicyclomycin (FPDB) and 5a-formylbicyclomycin
(FB) to 3.15, 3.05, and 3.15 A resolution, respectively. The structures show
that BCM and its derivatives are nonnucleotide inhibitors that interact with Rho
at a pocket adjacent to the ATP and RNA binding sites in the C-terminal half of
the protein. BCM association prevents ATP turnover by an unexpected mechanism,
occluding the binding of the nucleophilic water molecule required for ATP
hydrolysis. Our data explain why only certain elements of BCM have been amenable
to modification and serve as a template for the design of new inhibitors.
|
 |
 |
 |
|
 |
Figure 4.
Figure 4. Rho-BCM Contacts (A) Stereo view of BCM
(colored stick) bound to Rho. Amino acids involved in
coordinating BCM are shown as gray sticks (Table 3). Mg2+ and
ATPgS are shown as a magenta sphere and as black sticks.
(B) Schematic of Rho-BCM contacts. Protein residues are colored
black. BCM is shown in green. The additional contacts between
the protein and the aldehyde groups of FPDB (yellow) and FB
(blue) at the C(5a)-position of the [4.2.2] piperazinedione ring
are also shown.
|
 |
|
 |
 |
|
The above figure is
reprinted
by permission from Cell Press:
Structure
(2005,
13,
99-0)
copyright 2005.
|
 |
|
|
|
|
 |